Liquidia Corp. (LQDA)
28.64
+0.65
(+2.32%)
USD |
NASDAQ |
Oct 02, 16:00
28.49
-0.15
(-0.52%)
After-Hours: 20:00
Liquidia Enterprise Value : 2.451B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.451B |
| October 01, 2026 | 2.393B |
| September 30, 2026 | 2.595B |
| September 29, 2026 | 6.197B |
| September 28, 2026 | 6.463B |
| September 25, 2026 | 5.996B |
| September 24, 2026 | 6.220B |
| September 23, 2026 | 5.912B |
| September 22, 2026 | 6.015B |
| September 21, 2026 | 5.818B |
| September 18, 2026 | 5.858B |
| September 17, 2026 | 5.992B |
| September 16, 2026 | 5.998B |
| September 15, 2026 | 5.754B |
| September 14, 2026 | 5.717B |
| September 11, 2026 | 5.845B |
| September 10, 2026 | 5.944B |
| September 09, 2026 | 6.057B |
| September 08, 2026 | 5.929B |
| September 04, 2026 | 6.016B |
| September 03, 2026 | 6.014B |
| September 02, 2026 | 6.107B |
| September 01, 2026 | 5.860B |
| August 31, 2026 | 5.973B |
| August 28, 2026 | 5.930B |
| Date | Value |
|---|---|
| August 27, 2026 | 6.130B |
| August 26, 2026 | 6.257B |
| August 25, 2026 | 6.179B |
| August 24, 2026 | 6.160B |
| August 21, 2026 | 6.013B |
| August 20, 2026 | 6.229B |
| August 19, 2026 | 6.611B |
| August 18, 2026 | 6.521B |
| August 17, 2026 | 6.822B |
| August 14, 2026 | 6.531B |
| August 13, 2026 | 6.323B |
| August 12, 2026 | 6.919B |
| August 11, 2026 | 7.744B |
| August 10, 2026 | 8.009B |
| August 07, 2026 | 7.937B |
| August 06, 2026 | 7.866B |
| August 05, 2026 | 7.839B |
| August 04, 2026 | 7.773B |
| August 03, 2026 | 7.370B |
| July 31, 2026 | 7.393B |
| July 30, 2026 | 7.633B |
| July 29, 2026 | 7.634B |
| July 28, 2026 | 7.634B |
| July 27, 2026 | 7.420B |
| July 24, 2026 | 7.581B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Harmony Biosciences Holdings, Inc. | 1.857B |
| Johnson & Johnson | 644.86B |
| United Therapeutics Corp. | 20.46B |
| Amneal Pharmaceuticals, Inc. | 9.222B |
| Pfizer Inc. | 210.23B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 74.72M |
| Revenue (Quarterly) | 171.68M |
| Total Expenses (Quarterly) | 96.96M |
| EPS Diluted (Quarterly) | 0.7369 |
| Gross Profit Margin (Quarterly) | 93.10% |
| Profit Margin (Quarterly) | 43.52% |
| Earnings Yield | 4.76% |
| Operating Earnings Yield | 6.05% |
| Normalized Earnings Yield | 4.764 |